These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31308344)

  • 41. Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber.
    Nolte H; Maloney J; Nelson HS; Bernstein DI; Lu S; Li Z; Kaur A; Zieglmayer P; Zieglmayer R; Lemell P; Horak F
    J Allergy Clin Immunol; 2015 Jun; 135(6):1494-501.e6. PubMed ID: 25636947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sublingual immunotherapy for treating adult patients with allergic rhinitis induced by house dust mite among Chinese Han population: A retrospective study.
    Han M; Chen Y; Wang M
    Medicine (Baltimore); 2018 Jul; 97(30):e11705. PubMed ID: 30045332
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of sublingual tablets of house dust mite allergen extracts: Results of a dose-ranging study in an environmental exposure chamber.
    Roux M; Devillier P; Yang WH; Montagut A; Abiteboul K; Viatte A; Zeldin RK
    J Allergy Clin Immunol; 2016 Aug; 138(2):451-458.e5. PubMed ID: 27289490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in type 2 innate lymphoid cells and serum cytokines in sublingual immunotherapy in pediatric patients with allergic rhinitis.
    Wang X; Shen Y; Hong S; Kang H; Ke X
    BMC Pediatr; 2023 Jan; 23(1):13. PubMed ID: 36624390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytokine Responses to Specific Immunotherapy in House Dust Mite-Induced Allergic Rhinitis Patients.
    Li H; Xu E; He M
    Inflammation; 2015 Dec; 38(6):2216-23. PubMed ID: 26122703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.
    Virchow JC; Backer V; Kuna P; Prieto L; Nolte H; Villesen HH; Ljørring C; Riis B; de Blay F
    JAMA; 2016 Apr; 315(16):1715-25. PubMed ID: 27115376
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis.
    Bergmann KC; Demoly P; Worm M; Fokkens WJ; Carrillo T; Tabar AI; Nguyen H; Montagut A; Zeldin RK
    J Allergy Clin Immunol; 2014 Jun; 133(6):1608-14.e6. PubMed ID: 24388010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of house dust mite sublingual immunotherapy in monosensitized and polysensitized children with respiratory allergic diseases.
    Li P; Li Q; Huang Z; Chen W; Lu Y; Tian M
    Int Forum Allergy Rhinol; 2014 Oct; 4(10):796-801. PubMed ID: 25145986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Cost-Minimisation Analysis Comparing Sublingual Immunotherapy to Subcutaneous Immunotherapy for the Treatment of House Dust Mite Allergy in a Swedish Setting.
    Björstad Å; Cardell LO; Hahn-Pedersen J; Svärd M
    Clin Drug Investig; 2017 Jun; 37(6):541-549. PubMed ID: 28326466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of house dust mite sublingual immunotherapy tablets in allergic rhinitis: A systematic review and meta-analysis.
    Kulalert P; Phinyo P; Lao-Araya M
    World Allergy Organ J; 2022 Sep; 15(9):100691. PubMed ID: 36119654
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Evaluation of efficacy of 1 year after completing the 2-year specific sublingual immunotherapy treatment course in allergic rhinitis].
    Han L; You QJ; Li Z; Yang HH; Fang H; Zhang Y
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jul; 52(7):497-500. PubMed ID: 28728237
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
    Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
    Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IL-25 Could Be Involved in the Development of Allergic Rhinitis Sensitized to House Dust Mite.
    Kim DW; Kim DK; Eun KM; Bae JS; Chung YJ; Xu J; Kim YM; Mo JH
    Mediators Inflamm; 2017; 2017():3908049. PubMed ID: 28912627
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunotherapy for house-dust mite allergy.
    Nelson HS
    Allergy Asthma Proc; 2018 Jul; 39(4):264-272. PubMed ID: 30095391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Efficacy of sublingual immunotherapy with dermatophagoides farinae drops in children with allergic rhinitis and the change of TGF-β and IL-13 mRNA level].
    Wu YJ; Wang P; Liu ZX; Qiu SQ
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 32(4):256-259. PubMed ID: 29798500
    [No Abstract]   [Full Text] [Related]  

  • 57. State of the Art: Development of a Sublingual Allergy Immunotherapy Tablet for Allergic Rhinitis in Japan.
    Ohashi-Doi K; Lund K; Mitobe Y; Okamiya K
    Biol Pharm Bull; 2020; 43(1):41-48. PubMed ID: 31902930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Three-Year Course of House Dust Mite Sublingual Immunotherapy Appears Effective in Controlling the Symptoms of Allergic Rhinitis.
    Novakova SM; Novakova PI; Yakovliev PH; Staevska MT; Mateva NG; Dimcheva TD; Peichev JL
    Am J Rhinol Allergy; 2018 May; 32(3):147-152. PubMed ID: 29649893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and adherence of sublingual immunotherapy in patients aged 60 to 75 years old with house dust mite-induced allergic rhinitis.
    Chen H; Chen Y; Lin B; Huang S; Liu Q; Zheng H; Li R
    Am J Otolaryngol; 2020; 41(4):102538. PubMed ID: 32451288
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Developmental history of sublingual immunotherapy].
    Du W; Maekawa Y; Natsui K
    Nihon Yakurigaku Zasshi; 2019; 154(1):6-11. PubMed ID: 31308350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.